These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 951885)

  • 21. Heparin is unable to prevent contact activation by three different membranes.
    Stratta P; Canavese C; Mangiarotti G; Pacitti A; Tetta C; Coppo R; Ragni R; Vercellone A
    Proc Eur Dial Transplant Assoc; 1981; 18():269-74. PubMed ID: 6460241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Collagen materials in dialysis and implantation.
    Rubin AL; Riggio RR; Nachman RL; Schwartz GH; Miyata T; Stenzel KH
    Trans Am Soc Artif Intern Organs; 1968; 14():169-75. PubMed ID: 5701528
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute hemodialysis of a chronic dialysis patient without the use of anticoagulants.
    Izzo MS; Peters D
    Nephrol Nurse; 1983; 5(6):42-4. PubMed ID: 6560245
    [No Abstract]   [Full Text] [Related]  

  • 24. [Measurement of activated whole blood coagulation as a control parameter for heparin dosage in hemodialysis].
    Kraatz G; Lopot F
    Z Urol Nephrol; 1984 Aug; 77(8):465-71. PubMed ID: 6495895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative study of hemodialysis methods].
    Savchenko NE; Pilotovich VS; Shilaĭ LM; Slizskiĭ SI; Malobitskiĭ VI
    Ter Arkh; 1986; 58(8):84-7. PubMed ID: 3764768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experimental and clinical studies of methods for regenerating the dialysis solution].
    Eventov VL; Andrianova MIu; Maksimenko VA
    Urol Nefrol (Mosk); 1995; (4):25-7. PubMed ID: 7571196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rebound anticoagulation occurring after regional heparinization for hemodialysis.
    Blaufox MD; Hampers CL; Merrill JP
    Trans Am Soc Artif Intern Organs; 1966; 12():207-9. PubMed ID: 5960705
    [No Abstract]   [Full Text] [Related]  

  • 28. Risk factors of system clotting in heparin-free haemodialysis.
    Keller F; Seemann J; Preuschof L; Offermann G
    Nephrol Dial Transplant; 1990; 5(9):802-7. PubMed ID: 2129354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin kinetics during hemodialysis: variation in sensitivity, distribution volume, and dosage.
    Seifert R; Borchert W; Letendre P; Knutson R; Cipolle R
    Ther Drug Monit; 1986; 8(1):32-6. PubMed ID: 3961894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors affecting system clotting in continuous renal replacement therapy: results of a randomized, controlled trial.
    Ramesh Prasad GV; Palevsky PM; Burr R; Lesko JM; Gupta B; Greenberg A
    Clin Nephrol; 2000 Jan; 53(1):55-60. PubMed ID: 10661483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of coagulation during hemodialysis by a combination of the stable prostacyclin analogue CG 4203 and low-dose heparin.
    Maurin N; Ballmann M
    Clin Nephrol; 1988 Jul; 30(1):35-41. PubMed ID: 3061692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodialysis and heparin. Alternative methods of measuring heparin and of detecting activation of coagulation.
    Ireland HA; Boisclair MD; Lane DA; Thompson E; Curtis JR
    Clin Nephrol; 1991 Jan; 35(1):26-33. PubMed ID: 1826095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole-blood activated coagulation time for evaluation of heparin activity during hemodialysis: a comparison of administration by single-dose and by infusion.
    Wilhelmsson S; Lins LE
    Clin Nephrol; 1983 Feb; 19(2):82-6. PubMed ID: 6839556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperacute renal allograft rejection in the primate. Intrarenal effects of heparin and associated net release of factor VIII activity and kallikrein activation.
    Busch GJ; Kobayashi K; Hollenberg NK; Birtch AG; Colman RW
    Am J Pathol; 1975 Jul; 80(1):1-20. PubMed ID: 1098475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A single dose of a low molecular weight heparin fragment for anticoagulation during hemodialysis.
    Ljungberg B; Blombäck M; Johnsson H; Lins LE
    Clin Nephrol; 1987 Jan; 27(1):31-5. PubMed ID: 3815906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of coagulation during hemodialysis: effect of blood lines alone and whole extracorporeal circuit.
    Lucchi L; Ligabue G; Marietta M; Delnevo A; Malagoli M; Perrone S; Stipo L; Grandi F; Albertazzi A
    Artif Organs; 2006 Feb; 30(2):106-10. PubMed ID: 16433843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developments in dialysis for acute renal failure.
    Richards NT; Mansell MA
    Br J Hosp Med; 1986 Mar; 35(3):190-2. PubMed ID: 3527316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical use of a totally heparin grafted hemodialysis system in uremic patients.
    Schmer G; Teng LN; Vizzo JE; Graefe U; Milutinovich J; Cole JJ; Scribner BH
    Trans Am Soc Artif Intern Organs; 1977; 23():177-84. PubMed ID: 910332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Heparinization method and blood coagulation control during hemodialysis with the use of the "artificial kidney" apparatus].
    AGRANENKO VA; LEVITSKAIA LA; KAVESHNIKOVA BF
    Khirurgiia (Mosk); 1962 Oct; 38():51-8. PubMed ID: 14040964
    [No Abstract]   [Full Text] [Related]  

  • 40. Successful use of heparin-grafted hollow fiber dialyzers in sheep.
    Schmer G; Cole JJ; Vizzo JE; Scribner BH
    Kidney Int Suppl; 1975 Feb; (3):431-5. PubMed ID: 1057721
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.